Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

27.56

+0.98 (3.69%)

Jul 2, 2025, 10:10 AM - Market open

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jul '25 Jul 2, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2019
Market Capitalization	187	5	6	20	85	-	Upgrade
Market Cap Growth	5140.40%	-18.98%	-70.74%	-75.79%	-	-	Upgrade
Enterprise Value	147	0	0	14	67	-	Upgrade
Last Close Price	26.58	1.17	1.60	6.15	35.71	-	Upgrade
PB Ratio	4.83	1.19	1.23	2.67	5.51	-	Upgrade
P/TBV Ratio	4.83	1.19	1.23	2.67	5.52	-	Upgrade
Debt / Equity Ratio	0.00	0.02	0.01	0.01	-	-	Upgrade
Quick Ratio	87.64	10.92	24.16	8.00	31.12	5.30	Upgrade
Current Ratio	88.27	11.32	24.26	8.11	31.38	5.82	Upgrade
Return on Equity (ROE)	-11.21%	-46.18%	-86.02%	-99.95%	-85.94%	-124.04%	Upgrade
Return on Assets (ROA)	-10.57%	-25.19%	-47.45%	-57.32%	-51.52%	-61.70%	Upgrade
Return on Capital (ROIC)	-10.80%	-26.53%	-51.86%	-61.21%	-53.54%	-76.64%	Upgrade
Earnings Yield	-1.28%	-42.70%	-90.90%	-53.20%	-8.09%	-	Upgrade
Buyback Yield / Dilution	-39.99%	-15.87%	-50.58%	-37.64%	-148.42%	-74.24%	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q